期刊文献+

磷酸川芎嗪滴丸药物动力学研究 被引量:3

Study on the pharmacokinetics of ligustrazine phosphate dripping pills in healthy volunteers
暂未订购
导出
摘要 目的:探讨磷酸川芎嗪滴丸药物动力学特征。方法:20名健康志愿者,单剂量口服磷酸川芎嗪滴丸200mg,采用高效液相色谱法(HPLC)测定血清中药物的浓度,DAS2.0程序计算药代动力学参数。结果:磷酸川芎嗪滴丸主要药代动力学参数:Ka为(0.151±0.144)min,Tmax为(40.5±15.5)min,Cmax为(1.7±0.3)μg/ml,t1/2β为(67.7±3.2)min,CL/F为(0.017±0.004)L.min-1.kg-1,AUC0-300min为(181.5±40.3)μg.min-1.ml-1,AUC(0-∞)为(209.6±46.6)μg.min-1.ml-1。结论:单剂量口服磷酸川芎嗪滴丸200mg最佳房室模型为二室模型。 Objective:To studdy the pharmacokinetics of ligustrazine phosphate dripping pills. Methods:Twenty healthy volunteers were given a single oral dose of 200 mg ligustrazine phosphate dripping pills. The serum concentrations of ligustrazine were determined by high performance liquid chromatogram ( HPLC ). The pharmacokinetic parameters were calculated with DAS2. 0 practical pharmacokinetics program. Results: The main pharmacokinetics parameters of ligustrazine phosphate dripping pills were as follows : Ka was (0. 151 ±0. 144)min, Tmax was (40.5 ± 15.5)min,Cmax was (1.7 ±0.3) μg/ml,t1/2β was (67.7±3.2)min,CL/F was (0.017 ± 0. 004 ) L · min ^-1·kg^-1, AUC0-300 min was ( 181.5 ± 40.3 )μg · min^-1·ml^-1 and AUC(0-∞) was ( 209.6 ± 46.6 ) μg · min^-1·ml^-1 ,respectively. Conclusions :The preparation fits the two-compartment model best.
出处 《蚌埠医学院学报》 CAS 2007年第4期403-405,共3页 Journal of Bengbu Medical College
关键词 川芎嗪 高效液相色谱法 药物动力学 phosphate high performance liquid chromatogram phannacokinetics
  • 相关文献

参考文献7

二级参考文献25

共引文献114

同被引文献25

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部